Background: Mycetoma is a neglected infectious disease caused by a fungus (eumycetoma) or bacteria (actinomycetoma); it is characterized by chronic local inflammation with sinus formation and purulent discharge. Its course can be quite devastating because of the difficulty in diagnosing the infection and in eliminating the causative agent. Although endemic in many countries in the tropics and subtropics, the migration of Africans to Europe may increase the presence of this neglected disease in European countries. We present a case of an Eritrean patient living in a non-endemic country who was diagnosed as having an infection of Madurella mycetomatis in an atypical location in his body.

Case Presentation: We report the case of a 35-year-old African male refugee from Eritrea, living in Switzerland since 2015, who presented with a 1-year history of a painful soft tissue swelling associated with dark nodules in his right buttock. He mentioned having several previous surgeries after 2001 while he was in Eritrea due to recurrent abscess formation on this body area. In the previous months, the swelling had become more significant and nodules started draining a purulent fluid. An initial diagnostic hypothesis of buttock abscess was made and he was referred to a dermatologist for diagnostic confirmation and further specialist care due to the size and atypical presentation. After a punch biopsy, the diagnosis of eumycetoma was confirmed and cultures developed Madurella mycetomatis. The initial treatment approach consisted of oral treatment by itraconazole; however, a surgical resection of the lesions was finally needed.

Conclusions: Although rare, mycetoma should be diagnosed as early as possible to avoid long-lasting complications. Primary care physicians in European countries are frequently in the first line of care of migrant patients and therefore should be aware of the common and uncommon clinical presentations of mycetoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371586PMC
http://dx.doi.org/10.1186/s13256-018-1962-yDOI Listing

Publication Analysis

Top Keywords

madurella mycetomatis
12
european countries
8
mycetomatis infection
4
infection buttock
4
buttock eritrean
4
eritrean refugee
4
refugee switzerland
4
switzerland case
4
case report
4
report background
4

Similar Publications

Eumycetoma, a chronic fungal infection caused by , is a neglected tropical disease characterized by tumor-like growths that can lead to permanent disability and deformities if untreated. Predominantly affecting regions in Africa, South America, and Asia, it imposes significant physical, social, and economic burdens. Current treatments, including antifungal drugs like itraconazole, often show variable efficacy, with severe cases necessitating surgical intervention or amputation.

View Article and Find Full Text PDF
Article Synopsis
  • Mycetoma is a type of infection caused by fungi or bacteria, and identifying the specific agent is crucial for treatment success.
  • This study analyzed 32 mycetoma samples from patients, using advanced genetic techniques to identify the pathogens, focusing on different regions of DNA for various grain types.
  • The findings revealed a 59.4% identification success rate, with the fungal pathogen Madurella mycetomatis being the most common, and two potential new agents were also discovered.
View Article and Find Full Text PDF
Article Synopsis
  • * Current treatments for eumycetoma, largely relying on antifungal drugs and surgery, have low success rates and high chances of relapse.
  • * Researchers have synthesized 47 new chemical compounds that show better effectiveness and lower toxicity than existing treatments, particularly one compound that performed similarly to the standard drug itraconazole, suggesting they could be safer options for treating eumycetoma.
View Article and Find Full Text PDF

Background: Eumycetoma is an implantation mycosis characterised by a large subcutaneous mass in the extremities commonly caused by the fungus Madurella mycetomatis. Despite the long duration of treatment, commonly a minimum of 12 months, treatment failure is frequent and can lead to amputation. We aimed to compare the efficacy of two doses of fosravuconazole, a synthetic antifungal designed for use in onychomycosis and repurposed for mycetoma, with standard-of-care itraconazole, both in combination with surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!